Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$45.13 - $64.99 $1.6 Million - $2.31 Million
-35,514 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$29.77 - $84.85 $375,221 - $1.07 Million
-12,604 Reduced 26.19%
35,514 $2.25 Million
Q4 2020

Feb 16, 2021

BUY
$25.66 - $34.55 $611,298 - $823,084
23,823 Added 98.06%
48,118 $1.61 Million
Q3 2020

Nov 16, 2020

BUY
$22.51 - $30.11 $141,205 - $188,880
6,273 Added 34.81%
24,295 $664,000
Q2 2020

Aug 17, 2020

BUY
$12.65 - $29.57 $227,978 - $532,910
18,022 New
18,022 $487,000

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.